SAGE starts publishing official journal of International Dose-Response Society

SAGE today announces that it has begun publishing Dose-Response, the official journal of the International Dose-Response Society (ID-RS). The quarterly journal publishes research that measures the ecological, psychological and biological responses to substances in various quantities.

"After Dose-Response's decade of long record of growth and influence, the International Dose-Response Society is partnering with one of the major scientific publishers to expand the reach of its journal into the biomedical, clinical and environmental domains," commented editor-in-chief, Edward J. Calabrese, Ph.D. "SAGE is uniquely positioned to provide the journal access to these normally non-communicating disciplines, all concerned with issues of dose-response."

Dose-Response publishes experimental findings, mini-reviews on current topics and research on non-linear dose-relationships, characterized by effects that do not increase or decrease in correspondence with changing dosage amounts. The journal accepts qualified submissions that apply the concept of nonlinearity in dose-responses within drug and chemical testing, population-based studies and environmental, occupational and medical risk assessments.

ID-RS was formed in 2005 for the purpose of understanding the nature, mechanisms, and implications of the dose-response relationship as well as hormesis, a phenomenon in which a substance that's toxic in normal or high doses produces a favorable effect in low doses. Hormesis is a particular emphasis of the society, its journal, and a growing number of scientists across many biological disciplines today.

"SAGE is thrilled to partner with ID-RS and to publish a multidisciplinary journal that supports human and environmental health, among other areas of study," stated Bob Howard, Vice President of Journals, SAGE. "We look forward to extending its reach and deepening its connections across a range of sciences."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New AI tool maps millions of CD8+ T cells to advance disease research